Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ijrobp.2008.03.012
DC FieldValue
dc.titleIntraoperative Radiotherapy Combined With Adjuvant Chemoradiotherapy for Locally Advanced Gastric Adenocarcinoma
dc.contributor.authorFu, S.
dc.contributor.authorLu, J.J.
dc.contributor.authorZhang, Q.
dc.contributor.authorYang, Z.
dc.contributor.authorPeng, L.
dc.contributor.authorXiong, F.
dc.date.accessioned2016-11-29T01:19:36Z
dc.date.available2016-11-29T01:19:36Z
dc.date.issued2008-12-01
dc.identifier.citationFu, S., Lu, J.J., Zhang, Q., Yang, Z., Peng, L., Xiong, F. (2008-12-01). Intraoperative Radiotherapy Combined With Adjuvant Chemoradiotherapy for Locally Advanced Gastric Adenocarcinoma. International Journal of Radiation Oncology Biology Physics 72 (5) : 1488-1494. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ijrobp.2008.03.012
dc.identifier.issn03603016
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/131520
dc.description.abstractPurpose: To evaluate the efficacy of intraoperative radiotherapy (IORT) followed by concurrent chemotherapy and external beam RT (EBRT) in the treatment of locally advanced gastric adenocarcinoma. Methods and Materials: A total of 97 consecutive and nonselected patients with newly diagnosed Stage T3, T4, or N+ adenocarcinoma of the stomach underwent gastrectomy with D2 lymph node dissection between March 2003 and October 2005. Of the 97 patients, 51 received adjuvant concurrent chemotherapy (5-fluorouracil, leucovorin, docetaxel, and cisplatin) and EBRT (EBRT group) and 46 received IORT (dose range, 12-15 Gy) immediately after gastrectomy and lymph node dissection before concurrent chemoradiotherapy (EBRT+IORT group). Results: After a median follow-up of 24 months, the 3-year locoregional control rate was 77% and 63% in the two groups with or without IORT, respectively (p = 0.05). The 3-year overall survival and disease-free survival rate was 47% and 36% in the EBRT group and 56% and 44% in the EBRT+IORT group, respectively (p > 0.05). Multivariate analyses revealed that the use of IORT, presence of residual disease after surgery, and pN category were independent prognostic factors for locoregional control and that IORT, pN, and pT categories were independent prognostic factors for overall survival (p < 0.05). Four patients experienced Grade 3 or 4 late complications, but no significant difference was observed between the two groups. Conclusions: Radical gastrectomy with D2 lymph node dissection and IORT followed by adjuvant chemoradiotherapy appeared to be feasible and well-tolerated in the treatment of locally advanced gastric cancer. The addition of IORT to the trimodality treatment significantly improved the 3-year locoregional control rate. © 2008 Elsevier Inc. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ijrobp.2008.03.012
dc.sourceScopus
dc.subjectCarcinoma
dc.subjectChemoradiotherapy
dc.subjectGastrectomy
dc.subjectGastric
dc.subjectIntraoperative radiotherapy
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1016/j.ijrobp.2008.03.012
dc.description.sourcetitleInternational Journal of Radiation Oncology Biology Physics
dc.description.volume72
dc.description.issue5
dc.description.page1488-1494
dc.description.codenIOBPD
dc.identifier.isiut000261214600031
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

13
checked on Nov 19, 2021

WEB OF SCIENCETM
Citations

16
checked on Nov 19, 2021

Page view(s)

68
checked on Nov 18, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.